WA
AZN icon

WPG Advisers’s AstraZeneca AZN Stock Holding History

WPG Advisers’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Sell
1,054
-145
-12% -$27.3K 0.12% 104
2026
Q1 		$236K Buy
1,199
+110
+10% +$21.2K 0.17% 70
2025
Q4 		$200K Buy
1,089
+64
+6% +$11.2K 0.15% 93
2025
Q3 		$157K Buy
1,025
+22
+2% +$3.33K 0.12% 113
2025
Q2 		$140K Sell
1,003
-214
-18% -$30K 0.12% 118
2025
Q1 		$179K Sell
1,217
-327
-21% -$47.3K 0.17% 96
2024
Q4 		$202K Buy
+1,544
New +$216K 0.19% 99

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

WPG Advisers's AZN Position: Q2 2026 in Review

WPG Advisers reduced its AstraZeneca (AZN) stake by 12% in Q2 2026, selling an estimated $27.3K and leaving 1,054 shares worth $200K. The position accounts for 0.12% of the portfolio, ranked #104.

WPG Advisers first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $236K in Q1 2026. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • WPG Advisers held 1,054 shares of AstraZeneca worth $200K as of Q2 2026.
  • WPG Advisers sold 145 AstraZeneca shares in Q2 2026, an estimated $27.3K.
  • AstraZeneca made up 0.12% of WPG Advisers's portfolio in Q2 2026, its #104 holding.
  • WPG Advisers first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's AstraZeneca position peaked at $236K in Q1 2026.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.